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Abstract
MicroRNAs are small RNA molecules that regulate gene expression in cells. They
are derived from hairpin shaped RNA transcripts, and about 50 % of microRNA
genes are localized in genomic regions that are associated with cancer. There are
numerous other natural occurring RNA molecules that also take shape as hairpins.
Being able to distinguish between these molecules and real microRNAs is vital to
understand the nature of microRNAs.
The goal of this thesis has been to construct a classifier that based on existing
features is able to predict whether a hairpin shaped RNA molecule is a microRNA
or a pseudo-microRNA. In addition the features in use have been analyzed to see
which of these features are the most important for Microprocessor processing, and
microRNA classification.
I present a classifier that is able to distinguish between real and pseudo-microRNAs
with high certainty for mus musculus microRNAs. This classifier is based on fea-
ture information constructed from the output of another classifier that predicts the
Microprocessor cut site of microRNAs. The features used by this classifier have
been analyzed using feature elimination. Indications show that there are specific
positions within the flanking regions of a microRNA substrate that are important
for Drosha recognition of the substrate. Feature analysis has also been performed
for the microRNA classifier, and discoveries were made that indicate that microR-
NAs can be distinguished from other hairpin RNAs by the fact that microRNAs
have one clear cut site candidate where the other hairpin shaped RNAs might
have many possible candidates. This information will hopefully further assists the
search for novel microRNAs, and also to help reanalyze existing microRNAs to
verify that they are in fact microRNAs.
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Acronyms
A Adenine
C Cytosine
DGCR8 DiGeorgio Syndrome Critical Region 8
DNA Deoxyribonucleic acid
FN False Negative
FP False Positive
G Guanine
HMM Hidden Markov Model
hsa Homo sapiens
MFE Minimum Free Energy
miRNA microRNA
mmu Mus musculus
mRNA messenger RNA
ncRNA non-coding RNA
nt Nucleotide
pre-miRNA precursor microRNA
pri-miRNA primary microRNA
RISC RNA induced silencing complex
RNA Ribonucleic acid
ROC Reciever operating curve
Se Sensitivity
Sp Specificity
SVM Support Vector Machine
T Thymine
TN True Negative
TP True Positive
tRNA transfer RNA
U Uracil
Table 1: Accronyms
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Chapter 1
Introduction
MicroRNAs (miRNAs) are small non-coding RNAs of about 22 nucleotides in
length [Hammell, 2010]. They have been shown to be key actors during
development and other processes in cells [Erik Ladewig, 2012]. In many organisms,
disruption of miRNA biogenesis by mutations lead to early embryonic death, and
in the short amount of time we have known about miRNAs, the number of diseases
linked to misregulation of miRNAs has increased dramatically [Hammell, 2010].
MicroRNA precursors are characterized by forming a hairpin structure.
Unfortunately a large amount of similar hairpins can also be found, and being able
to separate between miRNAs and other hairpins is crucial to get insight into the
nature of miRNAs [Chenghai Xue and Zhang, 2005].
Human miRNAs are processed from primary miRNAs (pri-miRNA) into miRNA
precursors (pre-miRNAs) by the Microprocessor complex, consisting of Drosha
and DGCR8. The pre-miRNAs are then transported to the cytoplasm where it is
processed by Dicer into a double stranded RNA molecule. One of the two strands
ends up as the
functional mature miRNA while the other is degraded. The functional strand is
loaded into an RNA-induced silencing complex (RISC) before it can function as
an expression regulator [Hammell, 2010].
Computational methods of prediction provide an effective strategy for
identifying miRNAs where conventional genetics techniques are having problems
due to the short length of miRNAs, subtle phenotypes, or low expression levels
of many miRNAs [Hammell, 2010] [N. D. Mendes and Sagot, 2009]. As a result,
several sophisticated tools have been developed using methods such as Random
1
forest, hidden markov model and Support Vector machines, but none of these have
been based around the actual biogenesis of the miRNAs.
In 2007, Snorre A. Helvik et al. presented a classifier that was able to predict
the 5′ Drosha processing site in miRNA candidate hairpins [Snorre A. Helvik,
2007]. The information gathered from this classifier was in turn used to construct
a classifier for distinguishing between real and pseudo miRNAs.
This thesis is based on the work done by Helvik et al., and the purpose is to
continue the work started in the introduction project. Here the Drosha processing
site classifier was re-implemented with a new framework, see [Holst, 2012].
Furthermore the main goal has been to implement a SVM classifier that based on
a set of features first used by Helvik et al, is able to distinguish between real and
pseudo miRNAs. This classifier will be tested on new data sets constructed based
on findings done by Chiang et al. [H. Rosaria Chiang and Bartel, 2010].
In addition, a feature analysis for both the Microprocessor Cut site predictor and
the miRNA SVM classifier will be completed.
This thesis starts by giving the reader an introduction to key concepts from biology
that will be helpful to understand the remainder of the work. This introduction
is found in chapter two. In chapter three, the background for this work will then
be presented with a short summary of the work done by Helvik et al. along with
the main findings from the introduction project, and a brief summary of existing
methods for miRNA prediction. Chapter four will cover the Material and methods
used in this thesis, before the results will be presented and discussed in chapter
five. Chapter six presents the conclusion of this thesis. Finally chapter seven
suggests work that can be undertaken in the future to further expand upon the
knowledge obtained.
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Chapter 2
Biology
Genes are essential for function of cells, and therefore one of the key components
of life. They can be seen as the blueprint of an organism, and understanding the
blueprint will help us understand the organism itself.
Some genes contain the recipes on how to make proteins (coding genes) through
the protein synthesis (Section 2.7), while others have different functionality that
has been harder to identify (non-coding genes). One group of non-coding genes,
known as microRNA (miRNA) (Section 2.8), function by regulating protein
production in cells. MicroRNAs are the focus of this thesis, and in this
chapter, key concepts within the world of biology will be explained to give the
reader sufficient knowledge to understand the contents of this thesis.
2.1 Genome
The genome is the complete set of hereditary genetic material of an organism. It
can be seen as a cook book containing the recipes for all genes. Almost all cells
in the human body contain at least one copy of this book, an exception being the
red blood cells [Reece, 2010c].
The alphabet of this book is constructed from nucleotides that can be represented
as the letters A (Adenine), T (Thymine), C (Cytosine) and G (Guanine). Each
copy of the genome is approximately 3.2 billion nucleotides long [Reece, 2010b].
The building material of the genome is our DNA which is described in Section
2.2.
3
2.2 DNA
Deoxyribonucleic acid (DNA) is built up of nucleotide (nt) monomers consist-
ing of a sugar (deoxyribose) and a phosphate group comprising the backbone
together with one of four nitrogenous bases represented by the aforementioned
alphabet [Reece, 2010c].
The DNA structure usually takes shape as a double stranded helix where the
nucleotides are connected to the next one with a bond between the phosphate
group in the first molecule and the sugar in the next molecule [Reece, 2010c]. The
two strands are inversely complimentary to each other by connection between A in
strand one and T in strand two, and C in strand one and G in strand two and the
other way around. The bases together are held together by hydrogen bonds. The
direction of the strand is described based on the orientation of the nucleotides,
and is denoted as going from the 5′ to the 3′ end.
Figure 2.1: DNA helix [Reece, 2010d]
Figure 2.1 is an illustration of the DNA structure. The base complementarity
provides us with two strands that are inversely identical to each other and one can
be used to reconstruct the other.
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2.3 RNA
Ribonucleic acid (RNA) resembles DNA, but the sugar used in RNA is different
from the one used in DNA (ribose instead of deoxyribose). In addition, RNA uses
a different nitrogenous base than DNA. Here T is replaced with U (Uracil) [Reece,
2010d]. The structure of RNA molecules varies a lot more than the structure of
DNA molecules. Where DNA usually is structured as a double helix with two
strands that run inversely to each other, RNA can take more shapes by folding
and creating bonds between internal nucleotides. This structure is known as RNA
secondary structure, and one of the key characteristics of microRNA is based on
one of these structures [Reece, 2010d], more specifically the hairpin structure seen
in Figure 2.2 a.
Figure 2.2: RNA secondary structure examples [Matthias Hochsmann, 2003]
RNA molecules perform a variety of functions, often determined by the secondary
structure. Figure 2.2 b display the secondary structure of a transfer RNA (tRNA),
a molecule that is vital in the process of translating mRNA to proteins. This will
be described in more detail in Section 2.7.2.
To determine the secondary structure of an RNA based on its nucleotide sequence,
base pairing configurations are tested and the free energy is calculated based on
information such as number of GC versus AU and GU base pairs, number of base
pairs in stem regions and number of unpaired bases. The configuration that has
the least amount of free energy is called the Minimum Free Energy configuration.
This is often considered to be the most probable secondary structure of an RNA
molecule [Nelson and Istrail, ].
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2.4 Gene Expression
Gene expression is the process where the information carried by a gene is used to
produce a gene product. These gene products can be proteins or other functional
molecules such as microRNAs.
The variation in gene expression from cell to cell is what accounts for the dif-
ference in cell function. What this means is that even though every cell with a
genome have access to every recipe, only a few of the recipes are actually used.
The regulation of which gene and the amount of genetic product that is produced
is known as gene expression regulation. This regulation takes place in every step
needed for a gene to be expressed.
This thesis is concerned with the post-transcriptional regulation, as this is where
microRNAs act as a gene expression control mechanism [Jinju Han and Kim,
2006].
2.5 Amino acids
There are 20 different amino acids. Eight of these cannot be created in the hu-
man body (nine are needed by infants), meaning that they have to be ingested
through the diet [Reece, 2010d]. Amino acids are linked together by peptide bonds,
forming a chain of amino acids known as a polypeptide chain. These chains are
then processed to give the protein the correct structure, and in turn function,
which is determined by amino acid composition and polypeptide structure [Reece,
2010a].
2.6 Proteins
Proteins are large molecules constructed from chains of amino acids. They are
instrumental in almost every process in our cells, and make up nearly 50% of the
dry mass of most cells [Reece, 2010a]. Proteins are needed in the correct amounts
for a cell to function properly, and different proteins are expressed in different cell
types. Proteins act as building blocks, support structure, antibodies, hormones,
enzymes, mediators for cell response, and more.
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2.7 Protein synthesis
Protein synthesis is the process used to translate a gene into a protein. There
are numerous molecules involved in this process. A protein coding gene goes
through several steps to be translated into a functional protein, and the steps of
transcription and translation will be explained, as they are relevant to this thesis.
Figure 2.3 illustrates the different steps of the protein synthesis and molecules
involved.
Figure 2.3: Protein synthesis [excellence, 2009]
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2.7.1 Transcription
Simply put, the transcription step is the process where a gene is copied into an
RNA molecule. To do this, the DNA strands need to be unwound, making the
DNA available for transcription. Separated from the nontemplate strand, the
template strand can be copied before the DNA is rewound again. This happens
through three steps, initiation, elongation, and termination [Reece, 2010c]. Every
RNA molecule is processed through these steps, and they all happen in the nu-
cleus. But the RNA processing differs between RNA molecules. Figure 2.4 shows
the process of transcription.
Figure 2.4: Illustration of the transcription process [Reece, 2010c]
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2.7.2 Translation
Every amino acid in the transcribed gene can be described by a set of 3 nucleotides.
These three nucleotides are known as a codon. The process of translating the
mRNA molecule into a polypeptide chain is done by matching each codon with
an anti codon that is found at the base of the tRNA. The tRNAs transport amino
acids from the pool of amino acids present in the cytoplasm, and when the codon
and anti-codons are matched, the correct amino acid is attached onto a growing
polypeptide chain (a chain of amino acids linked with peptide bonds) by the
ribosomal unit. See Figure 2.5.
Figure 2.5: Illustration of the translation process [Reece, 2010c]
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2.8 MicroRNA
MicroRNAs (miRNA) are short non-coding molecules that act as a part of the reg-
ulatory network in animals and plants. They affect the gene expression of target
proteins through post transcriptional gene silencing.
More than one-third of our genes have been predicted to be regulated by miRNA,
and the combination of miRNAs in each cell therefore affect the use of thou-
sands of mRNAs [V. Narry Kim and Siomi, 2009]. MicroRNA molecules bind
to their target mRNAs and either repress translation or destabilize the mRNA
molecule [Jinju Han and Kim, 2006]. This interference leads to a down regulation
of protein production of the target mRNA.
MicroRNAs go through a process of maturation to yield a final mature single
stranded molecule. Figure 2.6 shows the microRNA biogenesis.
Figure 2.6: Biogenesis of microRNA [Mraz, 2012]
The transcribed molecule that is the precursor for mature miRNAs is known as
a primary miRNA (pri-miRNAs). Primary miRNAs are usually several kilobases
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long and contain one or multiple local stem loops.
The first step of maturation is performed by what is called a Microprocessor
complex in animals. This complex consists of a Drosha protein and a DiGeorge
syndrome critical region (DGCR8) protein. The pri-miRNA is cropped by the
Microprocessor complex to a hairpin-shaped molecule with a 60-70 nucleotide
stem loop with a 2 nt 3′ overhang. This is called a miRNA precursor or pre-
miRNA [Snorre A. Helvik, 2007] [Jinju Han and Kim, 2006] [Bartel, 2004]. Re-
search show that the secondary structure of a pri-miRNA is of more importance
than the primary sequence for substrate recognition by Drosha [Cullen, 2004].
The introduction to this thesis was to create a classifier that was able to pre-
dict where the microprocessor complex cut to yield the pre-miRNA product, and
data from this step is further used as features in the final classifier. Read more in
Section 4.3.
The pre-miRNA is transported from the nucleus to the cytoplasm by Exportin
5 that recognize the double stranded stem of the hairpin along with the over-
hang [V. Narry Kim and Siomi, 2009].
In the cytoplasm, the pre-miRNA is processed by a protein called Dicer. Dicer
cleaves the pre-miRNA near the terminal loop, producing a double stranded molecule
of approximately 22 nucleotides in length.
Finally the RNA duplex is loaded onto an Argonaute protein to produce a RNA
induced silencing complex (RISC). Only one of the strands from the duplex is used
(the mature miRNA) while the other is degraded [V. Narry Kim and Siomi, 2009].
It is worth mentioning that there are alternate ways to yield mature miRNA
molecules. One of which, bypass Drosha processing. This is the most preva-
lent of these pathways, giving rise to a group referred to as mirtrons. These
serve as pre-miRNA mimics and are not processed by the Microprocessor com-
plex [Erik Ladewig, 2012]. There are alternate pathways for other stages of the
miRNA biogenesis as well, but the miRNAs obtained through these pathways will
not be the focus of this thesis.
MicroRNA precursors are found to have a lower MFE in general than other short
non-coding RNAs (ncRNA), and thus MFE can be used to aid us in distinguishing
between miRNAs and other ncRNAs [Jiandong Ding, 2010]. There are also vari-
ations in the free energy throughout the stem of the miRNA created by internal
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loops at specific positions [Jinju Han and Kim, 2006].
Secondary structure features are essential to the recognition of miRNAs as they
are recognized by the various components in the biogenesis pathway and therefore
are essential for the processing of substrate. Loop size, and the flanking regions
of the loop has been shown to be critical in determining the cleavage site of the
Microprocessor complex [Jinju Han and Kim, 2006].
Recently V. C. Auyeuyng et al. concluded that secondary structure on its own
is inadequate to specify miNRA hairpins [Vincent C. Auyeung and Batel, 2013].
They came up with several primary-sequence features that also contribute to the
correct miRNA processing in human cells.
12
Chapter 3
Background
This chapter will in short introduce the basis for this project with foundation in
the work done by Helvik et al [Snorre A. Helvik, 2007]. It will then go through the
results obtained during the introduction project to this thesis, which was continued
and further used this semester. Finally existing methods of miRNA classification
will be discussed.
3.1 Basis for this project
This thesis is based on the work done by Helvik et al. presented in [Snorre
A. Helvik, 2007]. In short, a Support Vector Machine (SVM) classifier that is
able to predict the position the Microprocessor processing site in microRNAs is
described. The results from this classifier was in turn used as input for another
classifier that at the time gave more accurate results for finding unconserved miR-
NAs [Snorre A. Helvik, 2007]. Much of the frame-work from this paper has been
reused in the thesis. The main changes are that the data sets and the frame-work
used for the SVM classifier has been replaced.
3.1.1 Data Sets
The data sets used by Helvik et al. consisted of the entire set of human miRNA
sequences found in miRBase 8.0 (332 miRNAs) and the new human miRNA se-
quences from 8.1 (130 miRNAs). In addition an algorithm was used to extract
hairpins from the human genome.
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Processing Site Data Set
The data set used for the microprocessor SVM was constructed by finding can-
didate processing sites for each miRNA that fulfilled a set of secondary structure
requirements. The positive data set consisted of all candidates with the same cut
site as listed in miRBase.
miRNA SVM Data Set
The data set used for the miRNA SVM was a set of 3000 random hairpins as
negative data set, and the miRNAs from miRBase 8.0 as the positive set.
3.1.2 Features
The features used by Helvik et al. are derived both from structure and sequence,
but they will not be describes further here as they can be found in Section 4.3.
They are the same as the ones used in this thesis, and the methods for extracting
features have also been used to some extent.
3.2 Previous Work
Before Christmas, the introduction project was to reimplement a classifier that was
able to predict the Drosha processing site for miRNAs by using a new frame-work
for Support Vector Machines. This work was completed using the PyML machine
learning frame-work instead of the gist library which was used by Helvik et al.
More information about this project can be found in [Holst, 2012]. The outcome
of this project was a classifier that was able to predict a processing site within 2
nt from the real site in 69,3% for a subset of the verified miRNAs [Holst, 2012].
Various configurations ranging from different types of normalization to feature
value area scaling was tested to achieve the best possible performance at this
point. Figure 3.1 shows the optimal performance with features scaled to [-1, +1]
range and l2 normalization for the data sets.
14
Figure 3.1: The best results gained from cross validation of verified mmu
The data set used for this testing was a set of verified mus musculus (mmu) miR-
NAs. More information about the data sets used can be found in Section 4.5.
The verified data set was also used to train a SVM that in turn was used to
predict the cut sites for a group a miRNAs that were classified as false (see Sec-
tion 4.5). As can be seen from Figure 3.2, the false data set was harder to classify.
This indicate that there are distinguishable differences between the two data sets
suggesting that the two data sets will be useful for training a classifier that is able
to separate between real and pseudo-miRNAs.
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Figure 3.2: Result from training on verified and testing on failed
During this introduction project, PyML components were identified and input for-
mats were constructed. This work has been further improved upon and used as
the basis for this master thesis.
3.3 Existing Methods
Since the first discovery of miRNAs, several methods for miRNA gene finding
has been developed using various sets of features and tools. Common for most
of these is that they rely extensively on the conservation of miRNA between
species [N. D. Mendes and Sagot, 2009].
The various tools developed use different approaches to find new miRNAs. N.
D. Mendes et al. separate them into the groups filter-based methods, machine
learning methods, target centered methods, homology-based methods, and finally
Mixed approaches using a mix of the aforementioned methods [N. D. Mendes and
Sagot, 2009].
Filter-based methods use numerous criterions for filtering out good stem-loop
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candidates based on conservation and various features.
The Machine learning based methods use positive data sets of previously known
miRNAs and negative sets of stem-loops that are not miRNAs to attempt to gen-
eralize based on the information obtained from the data sets.
Target-centered methods use a set of assumed miRNA targets from conservation
studies to search for new miRNAs.
Homology-based methods use known pre-miRNAs and attempt to find similar stem-
loops this way.
The SVM method used in this thesis belong to the machine learning group, there-
fore this group will be described in more depth. I will take a look at a few other
methods of predicting miRNAs as this is done using several methods from the
machine learning toolbox.
ProMIR attempts to predict homologs of known miRNAs. This is done using a
co-learning method based on paired Hidden Markov Model (HMM) [Jin-Wu Nam,
2005]. ProMIR use minimum free energy(MFE) and structural characteristics such
as loop size and stem length as features for filtering.
MiPred distinguishes between real and pseudo miRNAs by using random forest
(RF). Random forest selects features from the set at random at each node when
growing a tree-structured classifier. MiPred uses MFE in addition to nucleotide
bonds combined in triplets as structural features [Peng Jiang and Lu, 2007].
MiRenSVM is a SVM-based approach to be used for detection of real miRNA
precursors. The features used by miRenSVM are derived from secondary struc-
ture and thermodynamic properties based around the difference between miRNA
MFE and the MFE of other small non-coding RNAs [Jiandong Ding, 2010].
17
18
Chapter 4
Material and Methods
This chapter will go through the tools, data and methods used to obtain the results
from this thesis. First I will explain the support vector machine, why it is used
and how it works. Then the ROCR package is mentioned as it was invaluable to
visualize the results obtained. The features used are described in detail to ensure
that they can be reproduced. The method of feature elimination is briefly described
before the data sets are introduced. Performance measures are explained. Cross
validation and normalization is mentioned before a short introduction to PyML is
given.
4.1 Support Vector Machines
As previously mentioned, the purpose of this project is to create a classifier that
can distinguish between true miRNAs and pseudo-miRNAs. The support vector
machine has been chosen as a means to achieve this goal.
The Support Vector Machine (SVM) is widely used in the field of computational
biology and bioinformatics [Asa Ben-Hur, ], and the popularity is due to the abil-
ity to deal with high-dimensional and large data sets. SVMs are also flexible for
modeling a variety of data sources. Since it is a binary classifier with the positive
traits mentioned, it is well suited to deal with the task at hand. This is vali-
dated by the fact that SVMs have been a popular framework for use in miRNA
classification, used to learn miRNA characteristics [N. D. Mendes and Sagot, 2009].
A support vector machine is a binary classifier that takes data as input in form of
numeric vectors. The numeric vector values are plotted in an x-dimensional space
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and a prediction is made based on which side of the maximum-margin hyperplane
that data point resides. The maximum-margin hyperplane is found by using a
training set with labeled input. Kernel functions are used to map the original
features to a feature space of higher dimension where an optimal hyperplane sep-
aration can be achieved [Peng Jiang and Lu, 2007].
We define the margin as the distance from the hyper plane to the closest fea-
ture vectors, known as support vectors. Of the possible hyperplanes, the one with
the maximum margin is chosen, hence the name maximum-margin hyper plane.
The hyperplane is described by (w,b) where the vector w is known as the weight
vector, and b, is the bias that translate the hyperplane away from the origin [Asa
Ben-Hur, ]. A data point in form of feature vector is placed on one of the sides of
the hyper plane based on the sign of the decision function described by Equation
4.1.
{f(x) = wTx+ b} (4.1)
The information for all miRNA candidates is contained in x and where xi denote
the ith vector. The dot plot of w and x is calculated and b is added. Based on the
score the points will be separated as the illustration in Figure 4.1 shows.
Figure 4.1: A linear SVM example [Asa Ben-Hur, 2008]
It is not always the case that all elements can be correctly predicted to be in the
correct group. To account for this, the soft margin is introduced to the SVM. The
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soft margin allows a number of the feature vectors to end up on the ”wrong” side
of the hyper plane.
The SVM requires the information available to be presented in an understandable
format as numerical vectors, so instead of feeding the raw information available
about each miRNA candidate to the support vector machine we need to transform
this data into numerical values. This information layer is referred to as ”features”.
The features used in this project are described in Section 4.3. In general the feature
vectors need to be described as numerical values. Chih-Wei Hsu et al. recommends
that the feature values are scaled down to the range [-1,+1] or [0,+1] in order to
avoid features with large numerical range to become dominating [Chih-Wei Hsu
and Lin, ].
To use the SVM, we need to train it first. This process finds the maximum-
margin hyper plane [Asa Ben-Hur, ]. The process of training the SVM is done by
supplying it with a data set of feature vectors that are already labeled +1 or -1
depending on which group they belong to.
The trained SVM can in turn be used to classify unknown data sets. In this project
a python library called PyML that contains an implementation of the SVM has
been used. More information onPyML can be found in Section 4.9
4.2 R and ROCR
R is a language and environment that is used for statistical computing, data
manipulation and graphical display [R-project, 2013]. It is designed to be highly
extensible, and produce high quality plots. R runs on windows, UNIX platforms
and MacOS.
ROCR is a package that is able to evaluate and visualize the performance of clas-
sifiers using various scoring schemes. It uses the statistical language R to produce
more than 25 performance measures that can be combined in two-dimensional per-
formance curves [Tobias Sing, 2005].
In this thesis R has been used with the ROCR library to plot ROC graphs based
on the decision function outputs from various data set tests.
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4.3 Features
In this thesis there are two sets of features that have been used (see Table 4.2).
For the processing site prediction, feature 1 through 8, and 11 were used. A short
description of each feature and representation will now be given in Section 4.3.1.
For the miRNA prediction, a set of new features was used. A description of how
each of these features were constructed will be given in Section 4.3.2
Figure 4.2 displays two illustrations of miRNA hairpins. Figure 4.2 (A) shows
the processing site candidates of a predicted miRNA secondary structure. The
true processing site as listed in miRBase is displayed in bold.
Figure 4.2 (B) displays the position of the regions where structural information
for feature 3 and 7, in addition to the features that are based on feature 3 and 7
has been obtained. Feature 3 is derived from the 24 nucleotide long region marked
with gray font and lines, while feature 7 is derived from the 50 nt long flanking
region marked with black font and lines.
Figure 4.2: MicroRNA feature figure [Snorre A. Helvik, 2007]
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4.3.1 MicroRNA Processing Site Features
Feature one consists of two values, one represents the loop size of the precursor,
and the other the length of the precursor.
Feature two is the distance from the 5′ processing site to the start of the loop.
Feature 3 contains position specific information about the bases in the 24 nu-
cleotide precursor base. Each possibility is described using binary values as de-
scribed in Table 4.3.1
• Adenine = [1,0,0,0]
• Cytosine = [0,1,0,0]
• Guanine = [0,0,1,0]
• Uracil = [0,0,0,1]
Table 4.1: Binary representation of the nucleotide bases.
Feature 4 contains base-pair information for each position in the region. This
information is represented with the values 0 if neither of the two nucleotides at
the specific position contains a bond to another nucleotide, 0.5 if only one of the
nucleotides contain a bond, and 1 if both contain a bond. Which nucleotide that
the bond is connected to is not being considered.
Feature 5 consists of the base frequencies in feature 3, one value for each base
in the 5′ and 3′ section.
Feature 6 contains the total number of base pairs in feature 4.
Feature 7 describes position specific nucleotide information for the 50 nucleotide
flanking region, totaling a 100 positions, 50 for each base in the 5′ and 3′ region
respectively. The nucleotieds are represented as described in Table 4.3.1.
Feature 8 contains the base pair information for feature 7 presented as described
in feature 4.
Feature 11 contains the number of base pairs in the feature 7 region.
To ensure that none of the features are weighted differently, they are scaled down
to [0,1] or [-1,1] range. This is done by finding the largest feature value for the
specific position, and dividing all values in that position for all the vectors by that
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value. Features 1, 2, 5, 6, and 11 have been scaled down.
4.3.2 MicroRNA features
For the miRNA classification, some features constructed from the information
gathered during the processing site classification have been added.
Feature 12, the number of potential processing sites, is simply the number of
cut site candidates produced for each miRNA.
The score of the best processing site (feature 13) is found by getting the high-
est scoring candidate based on the decision function. This decision function is set
as the best score.
Feature 14, the average processing site score, is calculated from the decision func-
tion of all processing site candidates of the given miRNA.
The standard deviation in feature 15 is calculated based on the decision func-
tion for every processing site candidate of the miRNA.
Feature 16 is calculated simply by subtracting feature 14 from feature 13.
The distance between the three top scoring processing sites (feature 17) is the
distance from top one to top two plus distance from top two to top three.
Feature 18 counts the number of local maximums, where the decision function
score is above a threshold (-0,5 in this case) and the decision function score is
higher than one of the neighbors.
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All features are summarized in Table 4.2
Features used by MicroRNAProcessingSiteSVM
ID Explanation
1 Precursor length and loop size
2 Distance from 5’ processing site to start of the loop
3 Nucleotide occurrences at each position in the 24 nt at
the precursor base
4 Base-pair information of each nucleotide for the 24 nt at
the precursor base
5 Nucleotide frequencies in the two regions in 3
6 Total number of base pairs in region 4
7 Nucleotide occurrences at each position in the 50 nt 5’
and 3’ flanking regions
8 Base-pair information of each nucleotide for the 48 nt in
the flanking region outside the precursor
9 Nucleotide frequencies in the two regions in 7
10 Total number of base pairs for the 15 nt immediately
flanking the precursor
11 Total number of base pairs in the region in 8
Additional Features used by MicroRNASVM
12 Number of potential processing sites
13 Score of the best processing site
14 Average score for all potential processing sites
15 Standard deviation for all potential processing sites
16 Difference between feature 13 and 14
17 Distance between the three top-scoring processing sites
18 Number of local maximums in the processing site score
distribution
Table 4.2: Features used in this project
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4.4 Feature elimination
To gain information on how useful each feature is for the SVM classification, a
feature elimination process can be conducted through various methods such as
Recursive feature elimination.
In this thesis, the information about the importance of each feature has been
studied by removing one feature. For every run a feature is left out, then the
classifier has been retrained and the performance has been compared to the clas-
sifier where every feature is still in use. This process has been repeated for every
feature, and has been completed both for the cut site classifier and the miRNA
classifier.
4.5 Data Sets
Every miRNA used in this project has been downloaded from miRBase. miRBase
is the repository for miRNA sequences that is most widely used [William Ritchie
and Rasko, 2012]. The miRNA SVM needed information from the microprocessor
cut site prediction to construct the complete data sets. How the different data sets
were constructed is described in the coming sections.
4.5.1 Microprocessor data sets
The Microprocessor classifier was constructed to predict where the Microprocessor
complex would cut the pri-miRNA to create the pre-miRNA. For each candidate
miRNA, every possible cut site vector with an attached cut site ID was generated.
The cut site that is registered by miRBase as the correct cut site was added to the
positive data set while the others were added to the negative data sets.
4.5.2 MicroRNA SVM data sets
As described in the feature section, the feature information needed for the vectors
in the miRNA classification is based on the decision function values extracted from
the cut site prediction. For each miRNA a cut site prediction is extracted, and
the decision function values for the candidate cut sites are used to determine the
feature vector to be used. This is the feature vector of the cut site with the highest
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scoring decision function. The additional features are then added to this feature
vector to create the miRNA vector that will be used for miRNA classification.
4.5.3 MicroRNAs used
In this project the miRNAs used are from the species homo sapiens (hsa), and mus
musculus (mmu). Table 4.3 describes the various data sets used in the miRNA
SVM part of this thesis. Appendix B contains the miRNA id for every miRNA
along with the fold it is put into and the label.
Chiang et al. completed an experimental evaluation of novel and previously
annotated miRNA genes for mmu. The results of this work can be found in
[H. Rosaria Chiang and Bartel, 2010]. One outcome was a list that presented
miRNAs that were verified as true miRNAs.
The different data sets are all subsets based on either all mmu miRNAs or hsa
miRNAs. Mmu all and hsa all are the complete sets of miRNAs from miRBase
that yielded precursors.
In this thesis the miRNAs from the list of verified mmu miRNAs that were also
present in mmu all from miRBase comprise the data set known as verified data
set. Chiang et al. also found several previous annotated miRNAs that failed to
fulfill the criteria for a miRNA. The subset of these that were also present in mmu
all make up the failed data set.
To generate a decision function score for the MMU miRNAs that are not cov-
ered by the verified data set or failed data set, another data set was constructed
by taking the precursors from mmu all that is not present in either set and put
these into the remaining MMU data set. An equivalent data set was constructed
for hsa giving us remaining HSA data set.
The training set for the miRNA SVM comprise the verified data set and the failed
data set as positive and negative data vectors respectively.
A hsa test set was generated by looking at the miRNAs from each fold when the
training set had been divided based on family. Each miRNA family was identified
based on the mmu miRNAs in that specific fold, then in turn the hsa miRNAs
from the identified families were collected and put into the corresponding fold in
the training set giving us the family in same fold HSA data set.
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A complete list of data sets used in this project can be found in Table 4.3
Data set Size Description
mmu all 654 Every mmu miRNA from miRBase that
yielded a precursor
failed data set 133 mmu miRNAs from mmu all found in list of
failed miRNAs
verified data set 475 mmu miRNAs from mmu found in list of ver-
ified miRNAs
correctly predicted
data set
184 mmu miRNAs from verified data set where
the predicted cut site matched the one regis-
tered in miRBase
remaining mmu 243 mmu miRNAs from mmu all that are neither
in verified data set nor failed data set
hsa all 1594 Every hsa miRNA from miRBase that
yielded a precursor
family in same fold
HSA data set
353 hsa miRNAs from mmu families found when
verified and failed data set were separated
into folds with family in same fold
remaining HSA 1241 hsa miRNAs that is not in family in same
fold HSA data set, but in hsa all
Table 4.3: Data set size and description
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4.6 Performance Measure
The performance of the two classifiers constructed in this project has to be mea-
sured in different ways as a result of the input in the two stages.
4.6.1 Performance measure for microRNA processing Site SVM
The input of the average microRNA contains approximately 15 candidate pro-
cessing sites. Only one of these candidates gets the status of being the correctly
predicted one, but since the candidates close to the real cut site can be alternative
cut sites we need a performance measure that account for the distance from the
real cut site.
The way the performance of the classifier is being displayed is by the use of a
bar graph. For each microRNA, the best candidate, meaning the candidate with
the highest scoring decision function, is registered. The cut site for this candidate
is extracted and compared with the correct cut site. The distance is calculated,
and based on this distance each microRNA is plotted in the bar graph as can be
seen in Figure 4.3
Figure 4.3: Bar graph displaying the performance of a miRNA processing site
classifier
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4.6.2 Performance Measure Feature Elimination cut site prediction
To evaluate the change in performance when removing features, the distance from
the true site has been calculated as described. This distance distribution has been
used to generate a cumulative frequency graph.
In a cumulative frequency graph each successive category is equal to the total
of the previous categories. Figure 4.4 displays the average distance distribution
from running feature evaluation on the verified data set.
Figure 4.4: Cumulative frequency graph displaying the average performance of a
miRNA cut site feature elimination
4.6.3 Performance for the microRNA SVM
Predicting whether a candidate is a miRNA or not, is a classic binary classifier
problem where the solution is either true or false. Based on this a miRNA can
either be true positive (TP), false positive (FP), true negative (TN), or false nega-
tive (FN). The number for each of these four categories have been calculated with
a decision function threshold of 0. If a decision function scored above 0, it was
considered a positive, otherwise it was considered a negative prediction.
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Based on these four categories, Sensitivity (Se) can be calculated using Equa-
tion 4.2 and Specificity (Sp) can be calculated using the Equation 4.3.
Se =
TP
TP + FP
(4.2)
Se =
TN
TN + FN
(4.3)
The performance of miRNA however, has been measured used receiver operating
characteristics (ROC) graphs. ROC graphs are used for visualizing and evaluating
classifier performance. They provide more details of classification performance
than other measures such as accuracy and error rate [Fawcett, 2006]. ROC graphs
have seen an increase in use for computational performance, and is seen as well
suited for use in machine learning [Fawcett, 2006]. Figure 4.5 shows a ROC graph
produced using the ROCR package for R.
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Figure 4.5: A ROC graph created using ROCR
The ROC curve plot the performance of a binary classifier based on the true
positive rate (Se) and false positive rate (Sp) when the decision function threshold
is varied.
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4.7 K-fold Cross Validation
K-fold cross validation is used to measure the predictive performance of a classifier,
and can be used to test how the SVM generalizes to unknown data sets. This is
done by working with a known data set where the correct predictions are already
known. The data set is divided into k sets of fairly equal size. The training set
comprise k-1 sets, while the test set is the remaining set that was left out. The
classifier is trained on the training set and tested on the test set. Then the solution,
and a performance measure for the fold is calculated. This process is repeated until
all k sets have been used as the test set. Figure 4.6 illustrate the cross validation
process.
Fold 0
Fold 5
Fold 1
Fold 6
Fold 2
Fold 7 Fold 8 Fold 9
Fold 4Fold 3
MMU Data set
Classify
Store 
results
Repeat for 
every fold
Fold 0
Train 
SVM
Fold 5
Fold 1
Fold 6
Fold 2
Fold 7 Fold 8 Fold 9
Fold 4Fold 3
Figure 4.6: Illustration of 10 fold cross validation
For the work with miRNAs, a random division can introduce bias to the results
as some miRNAs belong to the same family. What this means is that they have
evolved from the same sequence and thus share traits [Snorre A. Helvik, 2007].
The folds have been divided in such a way that miRNAs from the same family end
up in the same fold.
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4.8 Normalization
The data sets used for the microprocessor cut site classification is unbalanced due
to the number of possible cut sites. Since we have 15 possibilities and only one
correct cut site, the negative data set is a lot larger than the positive one. To
counter this imbalance the data sets have been normalized using built in data set
normalization from the PyML package. The normalization is done simply by using
data.normalize(norm). Where data is the data set to be normalized. Norm can be
either 1 or 2 resulting in either L1 or L2 normalization [Ben-Hur, b].
It is also possible to normalize the kernel, but this has not been done in this
project.
4.9 PyML
PyML is an object oriented machine learning framework supported for Unix/Linux
and Mac OS-X [Ben-Hur, b]. It is written in python, and contains an implemen-
tation of SVM that is used in this thesis to construct the two classifiers.
The SVM in PyML needs the data to be presented in one of several data con-
tainers provided by PyML. In this thesis the SparseDataSet container has been
used. The input format for each information vector has to follow the format pre-
sented in Table 4.4 in order to be accepted by the data containers in PyML.
[id,] label feature1:value feature2:value feature3:value feature4:value ....
Table 4.4: Input format for SparseDataSet container labeled
The id tag is optional, but is used in this thesis to validate that the decision func-
tion comes from the correct candidate. For known data sets, the label is either
+1 or -1 depending on if the vector is positive or not. For unknown data sets the
label omitted.
The kernels in PyML are attached with the constructed data set, and by de-
fault a linear kernel is used [Ben-Hur, b]. Other kernels can be attached if desired
but this has not been done in this thesis.
In this thesis, PyML implementation of the SVM has been used to construct
the classifier that generate decision functions and also other useful information
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contained in a result object. Table 4.5 summarizes the key elements used, and
how they were used.
The outcome What to use How it is used
Creating a SVM SVM() newSVM = SVM()
Training a SVM train() newSVM.train(knownDataSet)
Using created SVM to classify data test() result = newSVM.test(unknowndata)
Plot ROC plotROC() result.plotROC()
Table 4.5: How to construct, train, and use a SVM
In order to be able to plot the ROC curve, matplotlib must be installed on your
system. For more information about PyML see [Ben-Hur, a].
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Chapter 5
Results and Discussion
This thesis consists of several steps with results for every step. In this chapter the
results from each step will be presented and discussed in the order they have been
completed, starting with the additional results gained from the processing site
prediction. The results from feature elimination for the processing site classifier
will then be presented, after which the miRNA classifier will be discussed. Finally
the feature elimination results for the miRNA classifier will be presented.
5.1 MicroRNA processing site SVM results
As described in Section 3.2 a PyML classifier was implemented to predict the cut
site of a miRNA. During the spring semester, this work has been further adapted
to accommodate for more post processing of the results. This has made it possible
to create ROC curves for the two data set runs described.
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Figure 5.1 displays the ROC curve for a 10-fold cross validation run on the verified
data set. The performance here may turn out to be better than the ROC curve
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Figure 5.1: ROC plot for cross validation on the verified data set.
show. This is due to the theory that there may be more than one possible cut
site. These alternative cut sites are in that case positioned close to the real cut site
listed by miRBase. This is not accounted for when using this way of displaying the
results, but it does a good job displaying the performance in finding the correct
site which is useful when comparing the data sets.
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Figure A.5 shows the ROC plot for an SVM trained on the verified data set and
used to classify the failed data set.
Figure 5.2: ROC plot for a SVM trained on the verified data set and tested on the
failed data set.
These two ROC plots further support the theory that there are distinct differences
between the miRNAs in the verified data set and the failed data set. And that these
differences can be identified through the features generated for each candidate. We
can see this because the classifier is able to predict the correct Microprocessor cut
site with some certainty for the the verified data set, but is picking the cut site at
random for the failed data set. This is the same pattern that was observed in the
last project.
The output from the cut site prediction is a PyML result object and a result
map containing the miRNA id, the decision function score, and a label that is
either 0 or 1 depending on which data set the miRNA resides from. In addition
the id map contains the miRNA vector of the candidate with the highest scoring
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decision function. The number of candidates is added so that all the additional
features can be calculated to be used by the miRNA SVM.
5.2 Feature Elimination
To obtain information about the importance of each feature, every feature has been
analyzed by leaving one out as described in Section 4.4. The distance between true
cut site and the best cut site was estimated and used to create a cumulative dis-
tribution graph combining the performance of every feature.
Figure 5.3 presents the performance of the classifier as one feature is removed
at a time. The labels on the right refer to the feature that has been removed
by number. The label all displays the results from running the classifier with all
features included in the candidate vectors.
Figure 5.3: Diagram displaying the cumulative performance of each feature.
The main differences for each of the features can be found when we look at the
amount of miRNAs that had their best candidate scoring within the 2 nt window,
but the total amount distributed between these three distances are fairly equal for
the various features. With the exceptions being features 3,4,7, and 8. This can be
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seen more clearly when looking at Figure 5.4.
Figure 5.4: Cumulative distribution for the first 4 distances when removing each
feature one at a time.
The classifier that is trained without feature 3, which contain nucleotide informa-
tion for each position in the 24 nt at the precursor base, has the second worst
performance when looking at correctly predicted cut sites, but outperfroms the
other features when looking at the number of candidates predicted to be correct
that are actually within 2 nt from the real cut site.
The classifier that is without Feature 7, which contains the nucleotide occurrence
at each position in the 50 nt 3′ and 5′ flanking regions, underperforms all the other
classifiers up to a distance of 2 nt from the real site, but starts catching up with
the others at this point.
When removing feature 4 and feature 8, base-pair information for the region in
feature 3 and feature 7 respectively, little change in performance is observed for
the correctly predicted cut sites but the performance declines for the next two dis-
tances. At a distance of 2 nt from the real cut site, the classifiers without feature
4 and 8 have the worst performance. This may indicate that the base pairing is
important for the task of finding alternative cut sites for the Microprocessor. To
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further investigate this, more information about the possibility of alternative cut
sites must be obtained.
By looking at these results, it seems that the information contained in feature
7 is the most critical for correctly predicting the Microprocessor cut site, and
that a slight performance improvement may be obtained by removing feature 3
for classification of cut sites within 2 nt from the real site. Overall however the
performance is not greatly affected by removing one feature or the other when
looking at the classification within this distance. The largest difference is for the
correctly predicted cut sites where the classifier without feature 1 predicted 160
miRNA cut sites correctly while the classifier without featur 7 only managed to
correctly predict 129. This difference deminishes rapidly the further away from
the correct cut site we get, and at a distance of 2 nt the difference is only 9.
294 for the classifier without feature 3 and 285 for the classifier without feature
8. The difference obtained by removeing one feature or the other did not present
a result that is conclusive as to whether a feature should be removed or not. As
a result, all features are used for the remainder of the work presented in this thesis.
A new feature was constructed in order to replace feature 7 and feature 3. Instead
of looking at the nucleotide at each specific position, the new feature calculated
the base composition of nucleotide windows of length 6 or 12. When replacing the
information in feature 3 and 7 with the base pair composition feature the perfor-
mance dropped. It gave a better performance than removing all information of
the two features entirely, but quite a bit worse performance than when replacing
feature 3 and 7 with the base pair information. The largest difference was found
when replacing feature 7 with the new feature.
This indicates that there are nucleotide positions within the two regions that have
specific bases connected to them. Identifying these bases can further assist the
classifier performance in the future. Combining this information with the base
composition of the regions may turn out to be a better feature than the existing
ones.
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5.3 MicroRNA SVM results
A miRNA classifier, that based on the output from the miRNA processing site
SVM makes a prediction on whether or not a miRNA candidate is a real miRNA or
not, has been constructed. To test how this classifier generalizes to unknown data,
a 10-fold cross validation has been run on this classifier. The data sets consisting of
the verified data set and the failed data set and the family in same fold HSA data
set has been used for this purpose. These data sets were constructed as described
in Section 4.5. The verified data set and the failed data set were combined into
one set where the verified data set was labeled as positive while the failed data set
was labeled negative. The 10-fold cross validation run on the combined data set
resulted in the ROC curve plotted in Figure 5.5
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Figure 5.5: ROC plot for 10-fold cross validation on mmu verified and failed data
set.
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Compared to the performance of a random ROC curve, the result is better. But
the performance is not good by any means. When looking at the number of true
positives and true negatives with a threshold of 0, one can see that the classi-
fier performs ok when picking out the real miRNAs with regards to true positive
versus false positive rate. The sensitivity is 86,4% at this point, but the speci-
ficity is only 34 %. It is worth mentioning that the number of positive miRNAs
is quite a bit larger than the negative data set. If they were of the same size, the
performance would most likely drop even further as one could reasonably expect
the number of false positives to increase, which in turn would reduce the sensitivity.
The data set referred to as family in same fold HSA data set consists of two
lists of lists. One list contains the folds with the hsa miRNAs from families based
on the folds generated for the verified data set, while the other contains the equiv-
alent list for the failed data set. To obtain the miRNA vectors for the family in
same fold HSA data set, the process illustrated in Figure 5.6 was completed.
Run 10 fold cross 
validation on verified 
hsa data set
Generate new 
features
Train SVM on verified 
candidates
Use trained SVM to 
classify failed hsa 
candidates
Generate new 
features
Run 10 Fold cross 
validation
Processing Site SVM miRNA SVM
Figure 5.6: Flow chart for the process of generating HSA vectors.
The decision functions are obtained in a way that mimic the way the mmu miRNA
decision functions were generated in order to make the outcome as comparable as
possible. The process for the mmu data sets is identical except for how the 10-fold
cross validation was completed. Rather than training on the hsa data set, the
cross validation used two data sets as described in Figure 5.7.
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Fold 0
Fold 5
Fold 1
Fold 6
Fold 2
Fold 7 Fold 8 Fold 9
Fold 4Fold 3
MMU Data set
Train 
SVM
Classify
Store 
results
Fold 0
Fold 5
Fold 1
Fold 6
Fold 2
Fold 7 Fold 8 Fold 9
Fold 4Fold 3
HSA Data set
HSA
Fold 0
Fold 5
Fold 1
Fold 6
Fold 2
Fold 7 Fold 8 Fold 9
Fold 4Fold 3
Repeat for 
every 
Fold in HSA
Figure 5.7: 10-fold cross validation where the SVM is trained on mmu, and used
to classify the hsa folds.
The training set in this cross validation is constructed from the positive and neg-
ative folds in the same way as normal. The difference now is that instead of
classifying the last fold from the mmu set, the set to be classified is replaced with
the corresponding fold from the hsa set.
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The outcome of this test can be seen in Figure 5.8
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Figure 5.8: ROC plot for 10-fold cross validation on HSA data set.
The performance of the classifier when run on the family in same fold HSA data set
is close to the performance of a random ROC curve, so it appears as if the classifier
is unable to distinguish between the miRNAs from the positive and negative data
sets. The performance is comparable to that of the performance obtained when
training the cut site SVM on the verified data set and classifying the failed set.
An assumption was made when constructing the failed and verified data sets.
This assumption was that if a mmu miRNA was from the verified data set, the
hsa miRNAs from that family were true miRNAs as well.
In addition, the hsa data set was constructed without regard to the fact that
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the number of miRNAs found in a miRNA family varied. For instance, one family
contained 1 hsa miRNA but 9 mmu miRNAs. Other families did not contain hsa
miRNAs at all. This variation did in turn affect the variation of fold sizes. Since
the fold each hsa miRNA was to be put in was decided by which fold the miRNA
family came from regardless of the number in that fold, the fold size varied a great
deal as well. The smallest fold ended up being only two positive miRNAs. These
variations may result in a worse performance when classifying the hsa miRNAs
this way.
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5.4 SVM feature elimination
Removing one feature at a time did not present any large changes in performance.
The classifier did slightly worse without feature 3 and feature 7 (results not shown),
but the change was not of any conclusive scale. What did have a large impact how-
ever was training the classifier on a vector set containing the new features based
on the decision function, but not the original features used by the Microprocessor
classifier. The result of this new feature set can be seen in Figure 5.9.
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Figure 5.9: ROC plot for 10-fold cross validation of mmu with the new features.
The increased performance of the classifier when removing features may be ex-
plained by the fact that past a certain point, additional features can lead to worse
performance [Trunk, 1979]. Even though the number of features might not be that
high, each feature contains a varying number of numeric values. This number of
values range from 1 for several features up to 400 values for feature 7. The total
number of values in a vector is 684 when every feature is included. And only 9 for
the vector constructed only from the new features.
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There is a monumental difference between the performance of the classifier us-
ing all features, and the classifier that only uses the new features added. This
become apparent when looking at the ROC curves plotted in Figure 5.12.
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Figure 5.10: ROC plot for 10-fold cross validation of mmu with all features and
new features. The ROC curve for the classifier using all features is drawn with a
dotted line, while the ROC curve of the classifier using only the new features is
drawn using a solid line.
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To see if the change in performance held true for the data set constructed from hsa
miRNAs, a 10-fold cross validation was run in the same manner as described in
Section 5.3. The outcome of this cross validation can be seen in Figure 5.11.
False positive rate
Tr
u
e
 p
os
itiv
e
 r
a
te
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
−
0.
42
0.
06
0.
53
1
1.
48
1.
95
Figure 5.11: ROC plot for 10-fold cross validation of hsa with new features.
The performance is still close to that of a random classifier, and it did not adhere
to the expectation of results closer to that of the ones seen with the miRNA data
set from mmu. The expectation of a better performance was due to the concerva-
tion of miRNAs observed between human an mouse miRNAs.
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When comparing this ROC curve with the ROC curve plotted for the classifier
with all features one can see that the difference is negligible. This can be seen
clearly in Figure 5.12.
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Figure 5.12: ROC plot for 10-fold cross validation of mmu with all features and
new features. The classifier with new features only is drawn with a solid line while
the classifier with all features is drawn with a dotted line.
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Figure 5.13 compare the ROC plot for the results of the new features on the mmu
data set and the ROC plot for the results of the new features on the data set that
consist of hsa miRNAs.
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Figure 5.13: ROC plot for 10-fold cross validation of mmu with the new features
only drawn in a solid line, and for the hsa data set drawn in a dotted line
There maybe many reasons why the HSA data set does not perform as well as
the MMU set. None of the HSA miRNAs are actually verified. Instead the level
of conservation is assumed to be high enough that a verified miRNA from the
mmu family should be verified for the hsa family as well. This might very well
be the case, but since the data set was constructed with the possible sources of
error described in Section 5.3, the positive miRNAs in the hsa data set might not
be verified at all and vice versa. Further tests on other data sets is recommended
to make sure that the performance of the difference in performance is caused by
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varying quality of the data sets rather than a lack in ability to generalize to new
data sets from the classifier.
After the substantial change in performance while using only the new features
as described, the feature analysis focus shifted. Now the whole process needed
to be repeated for the new features only in order to be rid of the noise the other
features may be causing.
Feature 12 proved to be the least useful feature, and the classifier that was not
using this feature even managed to improve upon the performance obtained with
the new features only. This was to be expected as the number of processing site
candidates appeared not to be of importance for the processing of miRNAs.
The performance increase can be seen in Figure 5.14, where to ROC curve is
getting close to the performance of a perfect ROC.
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Figure 5.14: ROC plot for 10-fold cross validation without feature 12.
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Feature 13, 14, 17, and 18, namely Score of the best processing site, Average
score for all potential processing sites, distance between the top scoring sites, and
information about local maximums, had close to similar ROC curves to the one
produced with all features available. The ROC plot for these features can be found
in Appendix A.
Removing Feature 15 and 16 on the other hand proved to reduce performance
drastically. These two features are the standard deviation of the decision func-
tions for all processing sites, and the difference between the best processing site
and the average processing site. This indicates that it does not matter how good
the processing site is, just how much better it is than the other candidates.
This result does in turn supports the theory that a miRNA has one clear cut site
candidate whereas other hairpin shaped non-coding RNAs might have several cut
site candidates that score well. Figure 5.15 shows the ROC plot for the classifier
where feature 15 was removed. Feature 16 presented the same curve.
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Figure 5.15: ROC plot for 10-fold cross validation without feature 15.
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These findings can be used to further investigate reasons for the difference in per-
formance between the data sets based on mmu miRNAs and hsa miRNAs. More
on this in Section 7.
All miRNAs and pseudo-miRNAs from mmu in this thesis are as mentioned col-
lected from the miRNA data set found in miRBase, making the data set well suited
to test the performance of the miRNA created as they at some point have been
annotated as a real miRNA due to similarities with a real miRNA. However, as
the classifier here shows, there are clear differences between the miRNAs in the
data set, and all of the mmu miRNAs from the failed data sets are in fact treated
as pseudo-miRNAs because they were unable to fulfill one or more of the criteria
established for annotating a candidate as a real miRNA. I therefore extend the rec-
ommendation made by Helvik et al. that a distinction between verified miRNAs
and candidate miRNAs should be made.
53
54
Chapter 6
Conclusion
This thesis has been a continuation of the work done by Helvik et al. to further
explore the approach for miRNA classification presented there [Snorre A. Helvik,
2007]. I have investigated the possibility to reimplement a miRNA classifier that
based on information obtained by predicting the Microprocessor processing site
can distinguish between real and pseudo miRNAs. This has been done through
the construction of new data sets on which the classifier has been tested, and by
using a new framework for classification. The novelty of this research is attributed
mainly to the new data sets that have been introduced and subsequent feature
analysis.
I have presented the PyML implementation of a support vector machine classi-
fier. The outcome of this implementation is a classifier that is able to distinguish
between real and pseudo-miRNAs with high accuracy for mouse miRNAs.
As a part of the reimplementation process, the effect of removing features from
this classifier has been investigated. This has been done both for the Microproces-
sor cut site predictor and the miRNA classifier. This effort has shown that there
were no miRNA features that stood out as either clear performance enhancers or
performance inhibitors for the purpose of predicting the true cut site. However,
some variations were present. Through the construction of a new feature based
on information from feature 7, and by comparing it with the performance without
feature 7, the results indicated that positions within feature 7 should be examined
in more detail. In addition the removal of feature 3 showed that performance im-
provement might be obtained. These differences were however not of a scale that
called for a removal of the mentioned features.
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When eliminating the features for the miRNA classifier, the findings were of a
different nature. The changes were minor when removing one feature at a time.
At the same time, the performance of the classifier was poor when all features were
in use. When all but the new features were removed however, the performance
improved greatly. This performance was further improved by removing feature 12.
With the new insight the feature elimination was repeated for the new features
only, and feature 15 and 16, clearly distinguished themselves as the most impor-
tant features for the classifier performance. These features contained information
about the standard deviation of the decision function (feature 15), and the differ-
ence between the best cut site candidate and the average of all cut site candidates
for the given miRNA. This knowledge can in turn be used to investigate the dif-
ference in performance between the mouse data sets and human data sets.
It is important to remember that there are other pathways for a mature miRNA,
and that these are not processed by Drosha [Erik Ladewig, 2012]. This makes the
computational approaches described here unfit for finding these other miRNAs as
it relies on the Drosha processing. In addition, more tests of the classifier on new
data sets would be ideal to make sure that the difference in performance between
the human miRNAs and mouse miRNAs is in fact caused by varying quality of
the data sets rather than the miRNA classifier having problems with generalizing
to new data.
Even when considering the limitations of the research, the results obtained in this
thesis further support the theory that the information obtained about the Drosha
cut site can be used to further classify miRNAs as real or pseudo-miRNAs. This
can in turn help improving the set of known miRNAs. A good set of real miRNAs
will be of great importance to understand the nature of miRNAs, as this among
other things will help remove unnecessary noise from further studies.
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Chapter 7
Further work
This thesis has provided new information that can be useful in the endeavour to
get a better understanding of miRNAs, but there are also several questions that
arises. The results obtained indicated that there may be specific positions in the
flanking region that are important for correct processing of a miRNA substrate by
the Microprocessor complex. Identifying these positions could prove valuable to
get a better understanding of how Drosha recognize substrates.
In addition, the information obtained during the feature analysis can be used
to reanalyze why the results were so different between the data sets based on mmu
miRNAs and the data sets based hsa miRNAs. One can for instance take a look
at the hsa miRNAs that were assumed false due to conservation and calculate the
average scores for feature 15 and 16, this can in turn be compared to the same cal-
culation for the false mmu miRNAs. This can hopefully reveal information about
the similarities between these two data sets to see if the false hsa data set is in
fact false.
Finally, to compare the performance of the classifier constructed here to other
methods of classification, the other methods could be tested on the data sets used
here. This would give comparative results, and also yield information about how
the features used by other methods fare at the task of distinguishing between these
data sets.
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Appendix A
Feature elimination ROC curves
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Figure A.1: ROC curve, feature 13 removed
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Figure A.2: ROC curve, feature 14 removed
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Figure A.3: ROC curve, feature 16 removed
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Figure A.4: ROC curve, feature 17 removed
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Figure A.5: ROC curve, feature 18 removed
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Appendix B
MMU and HSA folds
B.1 MMU Folds
Fold 0
miRNA@mmu-mir-467a-1, Label: 1
miRNA@mmu-mir-669a-1, Label: 1
miRNA@mmu-mir-669b, Label: 1
miRNA@mmu-mir-669a-2, Label: 1
miRNA@mmu-mir-669a-3, Label: 1
miRNA@mmu-mir-467b, Label: 1
miRNA@mmu-mir-669c, Label: 1
miRNA@mmu-mir-466f-1, Label: 1
miRNA@mmu-mir-466h, Label: 1
miRNA@mmu-mir-467c, Label: 1
miRNA@mmu-mir-467d, Label: 1
miRNA@mmu-mir-466d, Label: 1
miRNA@mmu-mir-467e, Label: 1
miRNA@mmu-mir-466l, Label: 1
miRNA@mmu-mir-669d, Label: 1
miRNA@mmu-mir-669f, Label: 1
miRNA@mmu-mir-669h, Label: 1
miRNA@mmu-mir-669l, Label: 1
miRNA@mmu-mir-669m-1, Label: 1
miRNA@mmu-mir-669m-2, Label: 1
miRNA@mmu-mir-669o, Label: 1
miRNA@mmu-mir-466m, Label: 1
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miRNA@mmu-mir-669d-2, Label: 1
miRNA@mmu-mir-466o, Label: 1
miRNA@mmu-mir-467a-2, Label: 1
miRNA@mmu-mir-669a-4, Label: 1
miRNA@mmu-mir-669a-5, Label: 1
miRNA@mmu-mir-467a-3, Label: 1
miRNA@mmu-mir-669a-6, Label: 1
miRNA@mmu-mir-467a-4, Label: 1
miRNA@mmu-mir-669a-7, Label: 1
miRNA@mmu-mir-467a-5, Label: 1
miRNA@mmu-mir-669p-1, Label: 1
miRNA@mmu-mir-467a-6, Label: 1
miRNA@mmu-mir-669a-8, Label: 1
miRNA@mmu-mir-669a-9, Label: 1
miRNA@mmu-mir-467a-7, Label: 1
miRNA@mmu-mir-669p-2, Label: 1
miRNA@mmu-mir-467a-8, Label: 1
miRNA@mmu-mir-669a-10, Label: 1
miRNA@mmu-mir-467a-9, Label: 1
miRNA@mmu-mir-669a-11, Label: 1
miRNA@mmu-mir-467a-10, Label: 1
miRNA@mmu-mir-669a-12, Label: 1
miRNA@mmu-mir-466n, Label: 1
miRNA@mmu-mir-466g, Label: 0
miRNA@mmu-mir-568, Label: 0
miRNA@mmu-mir-466i, Label: 0
miRNA@mmu-mir-669j, Label: 0
miRNA@mmu-mir-669i, Label: 0
miRNA@mmu-mir-467g, Label: 0
Fold 1
miRNA@mmu-mir-466a, Label: 1
miRNA@mmu-mir-466b-1, Label: 1
miRNA@mmu-mir-466b-2, Label: 1
miRNA@mmu-mir-466b-3, Label: 1
miRNA@mmu-mir-466c-1, Label: 1
miRNA@mmu-mir-466e, Label: 1
miRNA@mmu-mir-466c-2, Label: 1
miRNA@mmu-mir-466b-4, Label: 1
miRNA@mmu-mir-466b-6, Label: 1
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miRNA@mmu-mir-466p, Label: 1
miRNA@mmu-mir-466b-8, Label: 1
miRNA@mmu-mir-103-1, Label: 1
miRNA@mmu-mir-103-2, Label: 1
miRNA@mmu-mir-107, Label: 1
miRNA@mmu-mir-450a-1, Label: 1
miRNA@mmu-mir-450a-2, Label: 1
miRNA@mmu-mir-450b, Label: 1
miRNA@mmu-mir-128-2, Label: 1
miRNA@mmu-mir-365-1, Label: 1
miRNA@mmu-mir-365-2, Label: 1
miRNA@mmu-mir-674, Label: 1
miRNA@mmu-mir-1930, Label: 1
miRNA@mmu-mir-3094, Label: 1
miRNA@mmu-mir-3062, Label: 1
miRNA@mmu-mir-488, Label: 1
miRNA@mmu-mir-3109, Label: 1
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